NCT07152249View on ClinicalTrials.gov

Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial

NARecruitingINTERVENTIONAL
Enrollment

13,120

Participants

Timeline

Start Date

September 3, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Postoperative NauseaPostoperative Vomiting
Interventions
OTHER

AW-D Clinical Decision Support Tool

The AW-D Clinical Decision Support Tool will test the automatic delivery of best practice advisories for antiemetic medications at critical timepoints in the perioperative period.

Trial Locations (1)

37212

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT07152249 - Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial | Biotech Hunter | Biotech Hunter